Healthy volunteers help uncover drug interaction for future HIV treatment
NCT ID NCT07199452
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 20 times
Summary
This study looked at how a tuberculosis drug called rifabutin changes the amount of a new HIV medicine, MK-4646, in the blood. 18 healthy adults took MK-4646 alone and then with rifabutin to compare drug levels and safety. The results will help doctors decide the right dose when both medicines are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortea CRU Madison ( Site 0001)
Madison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.